EpiBesançon 2022 10&11 May

6th edition of EpiCongress

EpiBesançon 2022  is the 6th edition of international epigenetics congress. This meeting is co-organized by the Niches and Epigenetics of Tumors Network of Canceropole Grand Ouest and the epignetics group of INSERM UMR1098. 

This congress is an opportunity for international researchers, PhD students, MD and private industrials to discuss about the development of epigenetic drugs through a better understanding of molecular mechanisms of epigenetics mainly in the field of cancer. Thus, communications will be performed with the goal to inform scientific community about recent and innovative researches in epigenetics in fundamental field and also in medicine/clinical applications.

Thus, we expect that this meeting would open the way to new epigenetic projects and promote new collaborations for your future research. After the virtual meeting that have been held in 2021 we are very happy to warmly welcome you in Besançon in May 2022.

Registration is open here ! Click here to register

Then go to Abstract Submission Guidlines if you want to submit a communication! (deadline 1st February 2022)

Keynote speaker

Mathieu Lupien, Single-cell chromatin accessibility in glioblastoma delineates heterogeneity within cancer stem cells,Toronto, Canada 
 

Speakers

Anaïs Bardet, title coming, Strasbourg, France

Jérôme Eeckhoute, Control of cellular identity in liver pathophysiology, Lille, France
 

Francesco Fazi, title coming, Roma Italy

Carmen Jeronimo, Epigenomics and epitranscriptomics: unravelling urological cancer biology and novel clinical biomarkers, Porto, Portugal

Olivier Joffre, ERV-derived genomic sequences control T helper cell differentiation, Toulouse, France

Hisham Mohammed, Multi-omic single-cell approach reveals transcriptional and epigenetic plasticity in hormone driven cancers Portland, USA

Denis Mottet, The BAF complex: more than a chromatin remodeling complex, Liege, Belgium (to be confirmed)

Marek Mraz, MicroRNAs in the regulation of  microenvironmental interactions of malignant B cells, Brno, Czeck Republic

Peter Mulligan, Characterization of a novel epigenetic regulator of breast cancer, Lyon, France 

Duncan Odom, Pervasive lesion segregation shapes cancer genome evolutionHeidelberg, Germany

Gilles Salbert, Epigenetic reprogramming of breast cancer cells, Rennes, France

Petr Svoboda, Small and long non-coding RNAs in mammalian oocytes, Prague, Czeck Republic

Céline Vallot, Tracking the dynamics of chromatin states in tumors cells at single-cell resolution:response and resistance to cancer therapies Paris, France